Clinical Trials Browser

Phase EARLY_PHASE1 × Unknown × Recurrence × Clear all

NCT05105867 2023-05-10

CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT05559177 2022-09-29

An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

Phase EARLY_PHASE1 Unknown

Urinary Bladder Neoplasms, Recurrence

NCT04626752 2020-11-13

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase EARLY_PHASE1 Unknown

Multiple Myeloma, Recurrence

NCT04315584 2020-03-24

FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

Phase EARLY_PHASE1 Unknown

Glioblastoma, Recurrence

NCT04169932 2019-11-20

The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell

NCT04028440 2019-09-26

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Peripheral

NCT04011293 2019-07-08

A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Neoplasms, Recurrence, Hematologic Neoplasms

NCT03799913 2019-04-10

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Phase EARLY_PHASE1 Unknown

Ovarian Neoplasms, Recurrence

NCT03661554 2018-09-10

BCMA CAR-T

Phase EARLY_PHASE1 Unknown

Multiple Myeloma, Recurrence

NCT03559764 2018-06-18

Study of BCMA CAR-T in Multiple Myeloma

Phase EARLY_PHASE1 Unknown

Multiple Myeloma, Recurrence